AIP
BNTX icon

Ameritas Investment Partners’s BioNTech BNTX Stock Holding History

Ameritas Investment Partners’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-100
Closed -$8.04K – 3133
2024
Q2 		$8.04K Hold
100
– – ﹤0.01% 2984
2024
Q1 		$9.22K Hold
100
– – ﹤0.01% 2832
2023
Q4 		$10.6K Hold
100
– – ﹤0.01% 2831
2023
Q3 		$10.9K Hold
100
– – ﹤0.01% 2808
2023
Q2 		$10.8K Hold
100
– – ﹤0.01% 2883
2023
Q1 		$12.5K Hold
100
– – ﹤0.01% 2643
2022
Q4 		$15K Hold
100
– – ﹤0.01% 2673
2022
Q3 		$13K Hold
100
– – ﹤0.01% 2701
2022
Q2 		$14K Hold
100
– – ﹤0.01% 2710
2022
Q1 		$17K Hold
100
– – ﹤0.01% 2616
2021
Q4 		$25K Hold
100
– – ﹤0.01% 2531
2021
Q3 		$27K Hold
100
– – ﹤0.01% 2526
2021
Q2 		$22K Hold
100
– – ﹤0.01% 2681
2021
Q1 		$10K Hold
100
– – ﹤0.01% 2845
2020
Q4 		$8K Hold
100
– – ﹤0.01% 2874
2020
Q3 		$6K Buy
+100
New +$7.17K ﹤0.01% 2908

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's BNTX Position: Q3 2024 in Review

Ameritas Investment Partners sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 100 shares — an estimated $8.04K sold.

Ameritas Investment Partners first reported a position in BNTX in Q3 2020 and held it in 16 quarters. The position peaked at $27K in Q3 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Ameritas Investment Partners reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 100 BioNTech shares in Q3 2024, an estimated $8.04K.
  • Ameritas Investment Partners first reported a position in BioNTech in Q3 2020 and held it in 16 quarters.
  • Ameritas Investment Partners's BioNTech position peaked at $27K in Q3 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Ameritas Investment Partners's 13F filing for Q3 2024, filed 13 Nov 2024.